Share on LinkedInShare on LinkedIn

ARTICLE · 15 FEBRUARY 2023

Senate Judiciary Committee Pushes Pharma Patents And Pricing Bills Forward

S. 113 was sponsored by Senators Grassley, Cantwell, Blumenthal, Blackburn, and Tillis.

United StatesIntellectual Property

It is hard to predict whether a given bill will gain traction, but when the Senate Judiciary Committee reports out five bipartisan bills targeting pharmaceutical patents and pricing, it seems likely they are determined to get something done. During the February 9, 2023 Executive Business Meeting, the Senate Judiciary Committee reported out the "Interagency Patent Coordination and Improvement Act of 2023" (S. 79), the "Prescription Pricing for the People Act of 2023" (S. 113), the "Preserve Access to Affordable Generics and Biosimilars Act" (S.142), the "Stop STALLING Act" (S. 148), and the "Affordable Prescriptions for Patients Act of 2023" (S 150).

The Interagency Patent Coordination and Improvement Act of 2023 (S. 79)

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from